Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID‐19

Shengyuan Luo(Rush University Medical Center), Yiyuan Huang(Affiliated Hospital of Youjiang Medical University for Nationalities), Evangelos J. Giamarellos‐Bourboulis(National and Kapodistrian University of Athens), Tariq U. Azam(University of Michigan), Tisha Suboc(Rush University Medical Center), Rodica Pop‐Busui(University of Michigan), Kingsley Amadi(University of Michigan), Erinleigh Michaud(University of Michigan), Chelsea Meloche(University of Michigan), Rayan Kaakati(University of Michigan), Annika Tekumulla(University of Michigan), Izzet Altintas(Hvidovre Hospital), Jeanne du Fay de Lavallaz(University Hospital of Basel), Patrick O’Hayer(University of Michigan), Élizabeth Anderson(Wellcome Sanger Institute), Kingsley‐Michael Amadi(University of Michigan), Hanna Berlin(University of Michigan), Pennelope Blakely(University of Michigan), Sven H. Loosen(RWTH Aachen University), Husam Shadid(University of Michigan), Rafey Feroze(University of Michigan), Tonimarie Catalan(University of Michigan), Michael Pan(University of Michigan), Alexi Vasbinder(University of Washington), Joanne Michelle D. Gomez(Cedars-Sinai Medical Center), Frank Tacke(Medizinische Hochschule Hannover), Salim S. Hayek(Emory University), Abbas Bitar(University of Michigan), Annabelle Santos Volgman, Lili Zhao(University of Michigan), Christopher Launius(University of Michigan), Ibrahim Khaleel(University of Michigan), Kishan Padalia(University of Michigan), Kim A. Williams, Danny Perry, Peiyao Zhao
Journal of the American Heart Association
August 4, 2022
Cited by 16


Related Papers